Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25106,888,1.10 [0.99-1.23],0.0660818289134676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25147,141,1.15 [0.89-1.49],0.2848472020737989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26679,152,1.36 [1.08-1.71],0.0099562118761839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19954,488,1.17 [1.02-1.35],0.0259584863449124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26618,91,1.19 [0.87-1.63],0.2720006058627264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25936,78,0.91 [0.63-1.31],0.6113952406106419
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27643,90,1.18 [0.86-1.62],0.2989970698412361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27664,63,1.28 [0.89-1.85],0.1886671742020531
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25375,46,1.40 [0.93-2.13],0.1099985269306035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27148,105,1.11 [0.83-1.50],0.4757776656225853
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27110,67,1.00 [0.68-1.47],0.9972134188739832
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27704,67,1.03 [0.71-1.51],0.8674473683698198
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27664,97,1.09 [0.80-1.49],0.5842124219159597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27656,89,1.08 [0.78-1.50],0.6501306062352618
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,27477,45,1.34 [0.88-2.05],0.1760673133606627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26840,382,1.18 [1.01-1.38],0.0358578635008841
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26602,144,1.18 [0.92-1.52],0.1934296032082871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26701,243,1.21 [1.00-1.47],0.0507649207290746
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24054,29,0.56 [0.29-1.06],0.0725712912200568
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24075,50,0.98 [0.74-1.31],0.9046006128390028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24149,124,1.22 [0.93-1.59],0.1467092810451163
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24152,127,1.22 [0.94-1.59],0.1362255615304101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13525,286,0.73 [0.59-0.89],0.0017515541276822
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",10812,26,0.69 [0.35-1.36],0.284856994326304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24072,47,1.15 [0.74-1.78],0.5471247005818108
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,25599,802,0.98 [0.88-1.10],0.7472000205155902
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26669,192,1.07 [0.86-1.34],0.550993050744913
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27295,79,1.01 [0.71-1.43],0.9680835094862738
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27779,69,1.15 [0.80-1.66],0.4511559581607692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,27551,45,1.27 [0.83-1.96],0.2707392074586138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27787,40,0.95 [0.57-1.58],0.8416982020680341
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Stomach,27823,33,1.05 [0.61-1.81],0.8591327636767153
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,27520,294,0.98 [0.82-1.18],0.8603943322209004
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27759,115,0.93 [0.69-1.25],0.6291397650856421
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27759,93,0.87 [0.62-1.22],0.4245701657893111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27726,47,0.65 [0.40-1.07],0.0926878590133625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",27728,47,0.65 [0.40-1.07],0.0927879372317304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,27624,249,1.08 [0.89-1.32],0.4504190512247678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27785,111,1.27 [0.96-1.67],0.1000280662100547
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,27694,190,1.13 [0.90-1.41],0.2845357429576713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of breast,15362,92,0.91 [0.65-1.27],0.571727140544783
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Leiomyoma of uterus,14999,692,0.97 [0.85-1.09],0.5764156352295613
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26811,195,1.18 [0.95-1.46],0.1410916701070991
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26709,348,1.03 [0.87-1.22],0.7027613537647717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26709,348,1.03 [0.87-1.22],0.7027613537647717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25511,357,1.19 [1.01-1.40],0.0350250182125579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27358,76,0.63 [0.43-0.93],0.0212896843944734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27558,108,1.36 [1.03-1.78],0.0273610802875979
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24418,701,1.37 [1.23-1.54],3.847992341850748e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26514,431,1.13 [0.97-1.31],0.1145269945355602
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26018,112,1.18 [0.89-1.57],0.2588710287344716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27069,55,1.46 [1.01-2.11],0.044560021200054
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26003,97,1.18 [0.87-1.61],0.2807120732677748
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26235,329,1.69 [1.44-1.97],4.494267603766089e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26225,319,1.69 [1.44-1.98],6.225878123215978e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25894,181,1.25 [0.97-1.60],0.079430920038448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25898,178,1.23 [0.96-1.59],0.1030748330962204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24258,541,1.34 [1.18-1.53],8.589749139604614e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",23791,74,1.33 [0.95-1.86],0.0984847623344601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24212,495,1.33 [1.16-1.52],4.1004369909425765e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23758,41,1.38 [0.90-2.14],0.1431038233148757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23794,77,1.54 [1.14-2.10],0.0055000695580656
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,24141,752,1.25 [1.11-1.39],0.0001049290352609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23674,285,1.11 [0.93-1.33],0.2518893282031357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27392,220,1.01 [0.82-1.24],0.9558343556186464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27462,158,1.22 [0.97-1.54],0.0889683769804052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25858,79,0.83 [0.58-1.19],0.310963644530924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27709,79,0.78 [0.54-1.11],0.1650127247336805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23468,79,0.83 [0.58-1.19],0.3218379938550243
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Alcohol dependence,25871,92,1.28 [0.95-1.73],0.1014392217327415
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,25841,65,1.42 [1.01-1.99],0.0416010426350888
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23462,73,1.47 [1.07-2.01],0.0171909276397944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23774,385,1.28 [1.10-1.49],0.0012056080979171
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression,26102,332,1.28 [1.09-1.50],0.0025888903180006
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression or dysthymia,23624,291,1.35 [1.14-1.59],0.0004197584781678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23531,142,1.51 [1.20-1.90],0.0004033136146607
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Other anxiety disorders,26320,65,1.35 [0.95-1.93],0.096756704374261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,24748,1432,1.10 [1.01-1.20],0.0258464462172896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23082,155,1.25 [0.98-1.58],0.0720177391788066
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27624,128,1.22 [0.94-1.59],0.1290494132433014
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26490,486,1.05 [0.91-1.21],0.5018590194935435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,26166,162,0.79 [0.61-1.02],0.0648761574367595
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,26105,101,1.33 [1.00-1.77],0.0526746317058933
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27462,91,1.40 [1.04-1.89],0.0250756773877371
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27343,41,1.18 [0.73-1.89],0.4974948191483005
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,26178,174,1.24 [0.99-1.56],0.0584644206380253
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,27210,135,1.18 [0.91-1.54],0.2030370509834179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26699,614,1.08 [0.95-1.22],0.2425815892087125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26221,136,1.09 [0.84-1.42],0.5332940723384686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26415,330,1.05 [0.89-1.25],0.5470571147053891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27610,85,1.18 [0.85-1.63],0.3277027534809184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,27579,54,1.19 [0.79-1.79],0.4154410117405219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,27397,122,0.96 [0.72-1.28],0.7735768755282375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27355,305,1.07 [0.90-1.28],0.440611071065755
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27218,168,1.13 [0.89-1.43],0.3103407624124855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27137,87,0.98 [0.70-1.38],0.9081003921296984
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27153,103,1.17 [0.87-1.58],0.2996537417459629
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27099,49,1.29 [0.84-1.97],0.2428300818761183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26130,66,1.30 [0.91-1.86],0.1460924960747188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26248,184,1.22 [0.98-1.52],0.0785449428880984
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27221,130,1.07 [0.81-1.40],0.6470191281441622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27572,25,1.42 [0.81-2.49],0.2189404539705841
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1745,25,1.05 [0.56-1.97],0.878283914483737
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25852,25,1.47 [0.84-2.58],0.1756869589120677
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27445,50,1.59 [1.09-2.33],0.017037684468226
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27423,28,1.83 [1.14-2.94],0.0125601826610618
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27362,94,1.05 [0.76-1.46],0.7468122088602693
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27405,99,0.96 [0.69-1.32],0.7813103953409176
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27701,119,1.25 [0.96-1.64],0.0992692616833621
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27303,91,1.14 [0.84-1.57],0.4001573130997282
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21783,1957,1.20 [1.11-1.29],2.3168988163484005e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27497,40,0.61 [0.36-1.05],0.07507234515547
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22827,1301,1.26 [1.15-1.37],5.776615491258377e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,22851,1325,1.27 [1.17-1.39],8.705050383363062e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21573,47,1.73 [1.20-2.48],0.0030678953636594
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26323,566,1.25 [1.10-1.42],0.0006761559773498
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,26107,350,1.28 [1.09-1.50],0.0023612256416007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27115,139,1.30 [1.01-1.66],0.0385767472671693
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27235,259,1.30 [1.08-1.56],0.0046314809205562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27717,59,1.14 [0.77-1.69],0.5170393337347712
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25914,157,1.30 [1.03-1.63],0.0278368082162318
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26171,425,1.19 [1.02-1.38],0.0247333128870631
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27309,80,1.23 [0.88-1.71],0.2209807225134674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27298,173,1.15 [0.91-1.45],0.2416667553218495
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27293,64,0.76 [0.50-1.15],0.1927640069219039
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27294,65,0.77 [0.51-1.15],0.2036153905894262
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21587,61,0.78 [0.51-1.19],0.2506912246118897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25212,46,0.87 [0.54-1.40],0.5589458827598104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,25241,75,1.32 [0.94-1.84],0.1069838909740522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19024,95,1.13 [0.83-1.54],0.4464957720188028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19119,190,1.12 [0.90-1.40],0.3095054427871101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,25209,43,1.37 [0.89-2.11],0.1506370619632582
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25228,62,0.97 [0.65-1.45],0.8714593633652623
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27326,120,1.25 [0.96-1.64],0.0999322118083282
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27297,115,1.28 [0.98-1.69],0.0725334449422993
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27329,86,1.31 [0.96-1.79],0.0910212174759634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27377,75,1.21 [0.86-1.70],0.2826694762594259
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27088,49,0.96 [0.61-1.50],0.8540179988468375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27122,83,1.29 [0.94-1.77],0.115017578918197
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26607,115,1.20 [0.91-1.59],0.2023349380031667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26586,94,1.33 [0.98-1.79],0.0646658499468109
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27659,89,1.33 [0.98-1.82],0.0674715145697283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,26917,425,0.94 [0.80-1.10],0.4353644295988749
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,27100,52,1.43 [0.97-2.11],0.0684133330749813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23544,1930,1.15 [1.07-1.24],0.0002284299412138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27604,137,1.36 [1.07-1.74],0.0129914096261795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26630,183,1.30 [1.05-1.61],0.0177912135536588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26604,157,1.32 [1.05-1.66],0.0183418558151223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27215,213,1.10 [0.89-1.36],0.3619220436792603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27213,211,1.10 [0.89-1.36],0.3752519936435744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26934,659,1.02 [0.91-1.16],0.7026316245400586
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,26367,92,0.99 [0.71-1.38],0.9470115383210526
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,26380,105,0.82 [0.60-1.13],0.2335405215342419
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26705,430,1.10 [0.95-1.28],0.2069721411158507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,26506,231,1.12 [0.92-1.37],0.2544045231420602
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16021,49,0.90 [0.57-1.42],0.6433978548699653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25463,872,1.13 [1.02-1.25],0.0248754688041083
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,27115,108,1.16 [0.87-1.54],0.315406696488988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27115,108,1.16 [0.87-1.54],0.315406696488988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27115,108,1.16 [0.87-1.54],0.315406696488988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26059,792,1.10 [0.98-1.22],0.1064303382106219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Asthma,21304,792,1.15 [1.02-1.28],0.0173459309055633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21163,792,1.14 [1.02-1.28],0.0176296260705686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21289,777,1.14 [1.02-1.28],0.0213251449811562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27638,58,1.26 [0.86-1.85],0.2424709703049877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,26507,44,1.12 [0.71-1.77],0.6152658279110038
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27696,44,1.13 [0.71-1.78],0.607027610279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26500,37,1.21 [0.74-1.96],0.4447131600087084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,26482,75,0.92 [0.64-1.34],0.6787831606195504
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,26586,179,0.95 [0.75-1.20],0.6656366917252183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26985,85,1.08 [0.77-1.51],0.6446383672632601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19677,5088,1.18 [1.12-1.24],2.7472618977371345e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27220,492,1.08 [0.94-1.25],0.2643864388050926
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27755,139,1.11 [0.86-1.44],0.4246352479504651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,27761,130,1.13 [0.87-1.48],0.3580998195066742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,26852,124,1.44 [1.12-1.84],0.0040878936688878
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26832,104,0.93 [0.68-1.27],0.6380150252039397
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27741,155,1.08 [0.84-1.39],0.5287651411882875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26822,94,1.18 [0.87-1.61],0.2958522050922136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26566,65,0.90 [0.60-1.33],0.592152770576142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27700,45,0.77 [0.47-1.26],0.3041163373432036
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22383,200,1.05 [0.84-1.31],0.6579334212227114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23913,1730,1.19 [1.11-1.29],5.8286896326950814e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,22450,267,1.23 [1.02-1.48],0.0281762782368451
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,22729,546,1.21 [1.06-1.38],0.0049267914548052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22246,63,1.30 [0.90-1.87],0.1569993072283135
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22314,131,1.38 [1.07-1.77],0.0119302380993806
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22214,31,0.83 [0.46-1.49],0.5285799492248024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,22283,100,1.02 [0.74-1.39],0.918571831838813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,22285,102,1.04 [0.76-1.41],0.8059128677016154
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27723,73,0.96 [0.66-1.38],0.8237388823091405
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,22281,98,1.24 [0.92-1.67],0.1558921601772102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22816,633,1.19 [1.06-1.35],0.0045936016510037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,27634,160,1.27 [1.01-1.60],0.0435640493284967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,22566,383,1.10 [0.94-1.29],0.2519255808592047
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22296,113,1.35 [1.03-1.77],0.0289168019866533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27627,182,1.18 [0.94-1.47],0.155457776611169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,27597,123,1.19 [0.91-1.56],0.2116945629467201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,25067,1157,1.09 [1.00-1.20],0.0622431477152795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,24295,385,0.96 [0.82-1.13],0.657707606469649
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,24030,120,1.05 [0.79-1.40],0.716257049302883
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,24003,93,1.18 [0.86-1.61],0.3012010578851664
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24501,591,1.24 [1.10-1.41],0.0006748689384323
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26937,744,1.21 [1.08-1.35],0.0007591452533016
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,22904,1643,1.12 [1.03-1.21],0.005554389639342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27492,70,1.27 [0.90-1.79],0.1824924705566737
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27739,98,1.22 [0.91-1.64],0.1921607272407386
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,26291,98,1.23 [0.91-1.65],0.1756158419646679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26267,74,1.12 [0.79-1.59],0.5188884038118111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27690,130,1.00 [0.76-1.32],0.9976879412544628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,26323,130,1.01 [0.76-1.33],0.9545021970782184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26305,112,1.04 [0.78-1.40],0.7870940107789708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26787,594,1.27 [1.12-1.43],0.0001250132432929
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26782,589,1.28 [1.13-1.45],7.574515808024078e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21329,68,1.06 [0.73-1.53],0.77733443650124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal stricture,27485,68,1.04 [0.71-1.51],0.8493437661486252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21307,46,1.07 [0.68-1.69],0.7573178280901187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21563,302,1.20 [1.01-1.43],0.0355445684812882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21434,173,1.36 [1.10-1.69],0.0052844510415499
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21510,249,1.18 [0.97-1.43],0.0926263294473124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,26651,222,1.13 [0.92-1.39],0.248873506401308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27406,79,1.54 [1.14-2.09],0.0046800431523761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21434,173,1.23 [0.98-1.54],0.067886175697372
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21347,86,1.06 [0.76-1.48],0.71673284031963
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22036,775,1.07 [0.96-1.20],0.2156913063942016
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,21442,181,1.09 [0.87-1.37],0.444825330239821
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27394,67,1.56 [1.12-2.16],0.0076973889681006
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,27087,119,1.29 [0.99-1.69],0.0575739296022627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,27032,64,1.37 [0.96-1.95],0.0849281283037177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26591,519,1.26 [1.10-1.43],0.0007149897368877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,26484,412,1.28 [1.11-1.49],0.0009247183164268
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,26151,79,1.44 [1.05-1.97],0.0228712121838223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26117,45,1.22 [0.79-1.90],0.3740050817666364
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,26131,59,1.35 [0.93-1.97],0.112603423246403
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27654,59,1.35 [0.93-1.97],0.1180942519846671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26569,280,1.40 [1.18-1.66],0.0001046627818893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26356,67,1.22 [0.85-1.75],0.2714989874398595
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,26341,52,1.28 [0.86-1.91],0.2262093550613481
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26331,42,1.52 [1.00-2.31],0.048985550812218
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26467,178,1.50 [1.22-1.84],0.0001112421093951
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,26462,173,1.48 [1.20-1.82],0.0002276534238463
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25246,1476,1.06 [0.97-1.15],0.1908471650279607
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27443,99,1.02 [0.74-1.40],0.9063386092272938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27394,457,1.10 [0.96-1.27],0.1793769845308117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26717,532,1.06 [0.93-1.22],0.3790747376038453
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27052,395,1.05 [0.90-1.23],0.5107484765140194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26762,105,1.02 [0.75-1.38],0.9047143114828252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26880,223,1.04 [0.85-1.29],0.6934600583469481
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27565,84,1.20 [0.87-1.66],0.262274365063596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27550,69,1.05 [0.72-1.52],0.8039873279706803
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27530,49,1.06 [0.69-1.65],0.7824697569778349
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27654,34,1.03 [0.60-1.77],0.9211201161923612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27651,31,0.99 [0.56-1.76],0.9826806130352936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27000,63,1.31 [0.92-1.88],0.1391108499024338
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27287,350,1.02 [0.86-1.20],0.8340384924412834
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26257,72,1.17 [0.82-1.67],0.3831982756497453
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26283,98,0.86 [0.62-1.19],0.3548244406194623
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26268,83,0.84 [0.59-1.21],0.3541292859753209
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26394,209,1.17 [0.95-1.43],0.1507588158545873
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26365,180,1.11 [0.88-1.39],0.3837239270609283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21525,3485,1.05 [0.99-1.11],0.0999139641523285
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23128,1841,1.03 [0.95-1.11],0.4818341496598765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25401,1103,1.12 [1.02-1.23],0.0221074279990049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21402,115,1.01 [0.75-1.35],0.9506542220363668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21625,338,1.20 [1.01-1.41],0.0349451675257393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27483,109,0.98 [0.73-1.33],0.8992637879197249
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27502,100,0.99 [0.72-1.35],0.9471010919751184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21943,656,1.11 [0.98-1.25],0.1093411200492545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24514,656,1.10 [0.97-1.25],0.1216214783381229
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21333,46,1.05 [0.66-1.67],0.8432162936693035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27438,45,1.04 [0.65-1.66],0.8791757968662074
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21440,153,1.21 [0.94-1.54],0.1330217077248215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21311,24,1.70 [1.01-2.87],0.0448514071143863
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21412,125,1.03 [0.78-1.36],0.8476344811194223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27714,60,0.90 [0.59-1.36],0.6063680968928506
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,21614,327,1.12 [0.94-1.33],0.2118407959630642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21512,225,1.14 [0.93-1.40],0.1948277249749849
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22510,1223,0.98 [0.89-1.07],0.6348215426184411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21324,37,1.44 [0.91-2.28],0.1205233688826255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21460,173,1.02 [0.80-1.30],0.8572769628207794
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21321,34,0.71 [0.40-1.27],0.2487025303421078
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21316,29,0.69 [0.37-1.31],0.2587134886732245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,21803,516,0.99 [0.86-1.14],0.9384863569895598
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21717,430,1.04 [0.89-1.21],0.6185178410775917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22016,280,1.11 [0.92-1.33],0.2881008017009739
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27431,151,0.64 [0.49-0.84],0.0014855263545982
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27321,41,0.62 [0.37-1.05],0.0749359939789593
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24862,48,0.59 [0.36-0.97],0.0357699193717688
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25029,215,0.98 [0.79-1.21],0.8330763874182787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,25710,896,1.10 [0.99-1.23],0.0634635279263945
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24948,134,1.03 [0.79-1.36],0.8096796410879805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24868,54,0.71 [0.45-1.11],0.1290686090676281
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25569,755,1.14 [1.02-1.27],0.0251874297062192
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24871,57,1.05 [0.69-1.58],0.8236162510526123
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25063,249,1.13 [0.94-1.38],0.1988367439978582
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24924,110,1.17 [0.88-1.56],0.2850964965786532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24885,71,1.20 [0.84-1.72],0.3183343433671769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24962,148,1.10 [0.85-1.42],0.4652118999179156
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24879,65,1.11 [0.76-1.62],0.6010565263065205
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25139,325,1.23 [1.05-1.46],0.0124078487007193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24585,287,1.09 [0.91-1.31],0.3579254649471304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24351,53,1.18 [0.78-1.78],0.4378074884099757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24354,56,1.19 [0.79-1.78],0.4106149411088686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24415,117,1.04 [0.78-1.39],0.7733365333987856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24353,55,1.46 [1.00-2.12],0.0482598499688265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24362,64,0.89 [0.59-1.33],0.5646472483480547
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24346,48,0.83 [0.52-1.33],0.4312283540102249
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24524,226,1.10 [0.90-1.36],0.3488791312677435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24348,50,1.31 [0.87-1.97],0.19478904378312
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24353,55,1.08 [0.71-1.65],0.7037189326581876
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24408,110,1.05 [0.78-1.41],0.7637381224119215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24370,72,0.82 [0.56-1.21],0.3219165849127148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24726,428,1.17 [1.01-1.35],0.0405571931483577
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24443,145,0.99 [0.76-1.28],0.9203637985481692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24519,221,1.20 [0.98-1.46],0.0826333042124382
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26439,100,1.07 [0.79-1.46],0.6490236939819365
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26677,338,1.14 [0.97-1.35],0.1158350968752639
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26394,55,1.19 [0.80-1.77],0.3972297312906461
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26406,67,0.97 [0.66-1.44],0.8923591709198372
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26454,115,1.25 [0.95-1.64],0.11499709955861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23519,4367,1.07 [1.01-1.12],0.0174836848955378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11274,409,1.01 [0.87-1.19],0.8679872541530836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26294,207,1.32 [1.08-1.61],0.0072507131868305
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26142,55,1.09 [0.72-1.64],0.690985679409571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26444,45,1.01 [0.64-1.60],0.9528151467965684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26447,48,1.68 [1.16-2.44],0.0065272812228009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26452,53,1.62 [1.13-2.31],0.0080950893841127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27451,234,1.20 [0.99-1.46],0.0658183636016816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27519,54,1.46 [1.01-2.12],0.0454277311076597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27377,160,1.03 [0.80-1.31],0.8390139080575691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27311,94,1.42 [1.06-1.89],0.0192957965006479
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26325,871,1.02 [0.92-1.14],0.6794161659851745
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,25536,82,1.16 [0.83-1.62],0.3880708105791024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25520,66,1.34 [0.94-1.91],0.1104811583712769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25633,179,1.25 [1.00-1.56],0.0503642686067118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25543,89,1.04 [0.74-1.45],0.8278259123451724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26063,609,1.02 [0.89-1.16],0.8092504634473009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10936,71,1.02 [0.70-1.48],0.9296043678952652
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10901,36,1.00 [0.59-1.71],0.9935593044718404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydrocele,10901,36,0.88 [0.51-1.52],0.6401261259260624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10956,91,1.41 [1.06-1.88],0.0172748129858404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10932,67,1.06 [0.72-1.55],0.7631284272024759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,10969,104,0.73 [0.53-1.02],0.0658906709397438
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15211,249,0.97 [0.79-1.19],0.783158626643565
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15033,71,0.84 [0.57-1.23],0.3641200725554964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15052,90,1.04 [0.74-1.45],0.836608659256674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15016,54,0.99 [0.64-1.53],0.9686011441132404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15173,388,1.09 [0.93-1.28],0.2965841121202442
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,14868,83,0.93 [0.65-1.32],0.6692674715158093
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14977,192,1.22 [0.98-1.52],0.0691212558285327
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,13979,2753,1.05 [0.98-1.13],0.1375791343014636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Endometriosis,11524,298,1.19 [0.99-1.42],0.0606574873446433
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11319,93,1.23 [0.90-1.68],0.1989180649522123
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11341,115,1.11 [0.83-1.48],0.4967246067477886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11527,301,1.02 [0.84-1.22],0.8727426886916342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11525,299,0.90 [0.74-1.09],0.272871113561034
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11695,469,0.98 [0.84-1.14],0.8110715104395894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11389,163,0.94 [0.73-1.22],0.6511672916662696
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11446,220,1.15 [0.94-1.42],0.1763305490427881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11308,82,0.97 [0.68-1.39],0.8795283098672388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11365,139,1.12 [0.86-1.45],0.413048986787522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15365,202,1.17 [0.94-1.45],0.1514333812031176
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15374,193,1.15 [0.92-1.44],0.2077296802856164
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15393,108,1.17 [0.87-1.57],0.3016750156507644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15385,118,1.21 [0.91-1.59],0.1887842080850128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11298,72,1.00 [0.69-1.45],0.9985363229275516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11286,60,0.75 [0.49-1.16],0.1974126601580709
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11300,74,1.28 [0.90-1.80],0.1649708897827037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Irregular menses,15288,378,1.00 [0.85-1.18],0.9852822374247642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12368,1142,0.99 [0.90-1.09],0.8388180113987787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12009,783,0.98 [0.87-1.11],0.780950543053231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15372,156,0.95 [0.73-1.22],0.6717747804929685
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11573,347,0.98 [0.82-1.17],0.8317790105386901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11499,273,1.02 [0.84-1.24],0.8100158244324233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11492,266,1.15 [0.94-1.39],0.1686500267963496
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female infertility,11340,114,1.21 [0.91-1.61],0.1980799711431708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11333,107,1.21 [0.90-1.63],0.2043206294054349
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15387,862,1.02 [0.91-1.15],0.7272158682003361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15394,1182,0.98 [0.88-1.09],0.7392486722632275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15388,468,1.05 [0.90-1.22],0.5323039039320704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15057,137,1.00 [0.76-1.31],0.9876593643818116
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15103,183,1.07 [0.84-1.36],0.587440118284691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15084,164,1.18 [0.93-1.51],0.1720421029827863
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15407,166,0.94 [0.73-1.21],0.6328371455607497
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15409,163,0.91 [0.70-1.18],0.4648756911322168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15404,409,1.05 [0.89-1.23],0.5858371115502381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15118,123,0.92 [0.69-1.24],0.6024013448733081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15222,227,1.10 [0.88-1.36],0.4044873024282387
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14669,144,1.36 [1.05-1.75],0.0180969423120625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14722,197,1.03 [0.81-1.30],0.8349313708296404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,14770,245,0.97 [0.79-1.20],0.7997244425781367
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14671,146,0.85 [0.64-1.12],0.2541552900974854
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14660,135,0.99 [0.75-1.32],0.9557027205907944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14673,148,0.73 [0.55-0.97],0.0325196658204981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14442,230,0.91 [0.73-1.13],0.3901984460403586
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14640,428,1.00 [0.85-1.18],0.9600492414799444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,14871,659,0.98 [0.85-1.12],0.7423238862187991
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15409,171,0.94 [0.73-1.21],0.6452564674137604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,13983,129,0.79 [0.59-1.07],0.129418992009388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14316,104,0.92 [0.67-1.27],0.6080468594834946
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15416,331,0.80 [0.66-0.96],0.0190765614930571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15335,250,0.81 [0.65-1.01],0.0603220677591426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15403,247,0.94 [0.76-1.17],0.5898673830524841
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15393,237,0.95 [0.76-1.18],0.619602647853366
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27580,37,0.99 [0.59-1.67],0.9691425847177976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26182,521,0.88 [0.76-1.02],0.0802600496020067
